Seychelles vs Palestine: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Seychelles
99.0%
in 2025
Palestine
99.0%
in 2025
Seychelles rank
1st
Palestine rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Seychelles
- Palestine
How they compare
Seychelles currently reports 99.0% against 99.0% in Palestine, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Palestine ahead.
Seychelles ranks 1st and Palestine ranks 1st of 194 countries.
Palestine has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Seychelles | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 10.8% | 71.3% | 60.5% | Palestine |
| 2020s | 95.8% | 96.2% | 0.3% | Palestine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Seychelles or Palestine?
- Seychelles, at 99.0% against 99.0% in Palestine as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Seychelles and Palestine?
- 0.0%, with Seychelles ahead.
- How many years of comparable data are there for Seychelles and Palestine?
- 18 years are reported by both, from 2008 to 2025.
- How do Seychelles and Palestine rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Seychelles ranks 1st and Palestine ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.